Immunosuppressive therapy for acquired severe aplastic anemia (SAA): A prospective comparison of four different regimens

Experimental Hematology

Volumn 34, Issue 7, 2006, Pages 826-831

  Zheng, Yizhou ^a   Liu, Yongze ^a   Chu, Yulin ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; ERYTHROPOIETIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; IMMUNOGLOBULIN; RECOMBINANT PROTEIN; STANOZOLOL; TESTOSTERONE PROPIONATE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; AGED; APLASTIC ANEMIA; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TIME SERIES ANALYSIS; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; ANEMIA, APLASTIC; CHILD; CHILD, PRESCHOOL; ERYTHROPOIETIN, RECOMBINANT; FEMALE; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EQUIDAE; ORYCTOLAGUS CUNICULUS;

EID: 33745438684     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2006.03.017     Document Type: Article

References (39)

1. Young N.S. Acquired aplastic anemia. Ann Intern Med 136 (2002) 534-546
2. Young N.S., and Maciejewski J.P. The pathophysiology of acquired aplastic anemia. N Engl J Med 336 (1997) 1365-1372
3. Jacobs P. Bone marrow failure: pathophysiology and management. Dis Mon 41 (1995) 201-289
4. Anasetti C., Doney K.C., Storb R., et al. Marrow transplantation for severe aplastic anemia. Ann Intern Med 104 (1986) 461-470
5. Storb R. Bone marrow transplantation for aplastic anemia. Cell Transplant 2 (1993) 365-370
6. Ades L., Mary J.Y., Robin M., et al. Long-term outcome after bone marrow transplantation for severe aplastic anemia. Blood 103 (2004) 2490-2497
7. Camitta B.M., and Doney K. Immunosuppressive therapy for aplastic anemia: indications, agents, mechanisms, and results. Am J Pediatr Hematol Oncol 12 (1990) 114-122
8. Champlin R.E., Ho W., and Gale R.P. Antilymphocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial. N Engl J Med 308 (1983) 113-118
9. De Planque M.M., Bacigulapo A., Wursoh A., et al. Long-term follow-up of severe aplastic anaemia patients treated with antilymphocyte globulin. Br J Haematol 73 (1989) 121-126
10. Hinterberger-Fischer M., Hocker P., Lechner K., Seewann H., and Hinterberger W. Oral cyclosporine A is effective treatment for untreated and also previously immunosuppressed patients with severe marrow failure. Eur J Haematol 43 (1989) 136-142
11. Speck B., Gratwohl A., Nissen C., et al. Treatment of severe aplastic anemia. Exp Hematol 14 (1986) 126-132
12. Young N.S., Griffith P., Brittain E., et al. A multicenter trial of antilymphocyte globulin in aplastic anemia and related diseases. Blood 72 (1988) 1861-1869
13. Young N.S., and Barrett A.J. The treatment of severe acquired aplastic anemia. Blood 85 (1995) 3367-3377
14. Frickhofen N., Kaltwasser J.P., Schrezenmeier H., et al. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. N Engl J Med 324 (1991) 1297-1304
15. Rosenfeld S.J., Kimball J., Vining D., and Young N.S. Intensive immunosuppressive with antithymocyte globulin and cyclosporine as treatment for severe aplastic anemia. Blood 85 (1995) 3058-3065
16. Paquette R.L., Tebyani N., Frane M., et al. Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: comparison with bone marrow transplantation. Blood 85 (1995) 283-290
17. Vadhan-Raj S., Buescher S., Broxymer H.E., et al. Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor. N Engl J Med 319 (1990) 1628-1634
18. Hord J.D., Gay J.C., Whitlock J.A., et al. Long-term granulocyte-macrophage colony-stimulating factor and immunosuppression in the treatment of acquired severe aplastic anemia. J Pediatr Hematol Oncol 17 (1995) 140-144
19. Bacigalupo A., Broccia G., Gorda G., et al. Antilymphocyte globulin, cyclosporine and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party. Blood 85 (1995) 1348-1353
20. Bacigalupo A., Bruno B., Saracco P., et al. Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. Blood 95 (2000) 1931-1934
21. Kojima S. Use of haematopoietic growth factors for treatment of aplastic anaemia. Bone Marrow Transplant 18 Suppl 3 (1996) S36-S38
22. Takahashi M., Aoki A., Mito M., et al. Combination therapy with rhGM-CSF and rhEpo for two patients with refractory anemia and aplastic anemia. Hematol Pathol 7 (1993) 153-158
23. Hanazono Y., Sasaki K., Nitta H., Yazaki Y., and Hirai H. Erythropoietin induces tyrosine phosphorylation of the beta chain of the GM-CSF receptor. Biochem Biophys Res Commun 208 (1995) 1060-1066
24. Shao Z., Chu Y., Zhang Y., Chen G., and Zheng Y. Treatment of severe aplastic anemia with an immunosuppressive agent plus recombinant human granulocyte-macrophage colony-stimulating factor and erythropoietin. Am J Hematol 59 (1998) 185-191
25. Camitta B.M., Thomas E.D., Nathan D.G., et al. Severe aplastic anemia: a prospective study on the effect of early marrow transplantation on acute mortality. Blood 48 (1976) 63-70
26. Betticher D.C., Huxol H., Muller R., Speck B., and Nissen C. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia. Exp Hematol 21 (1993) 1517-1521
27. Maciejewski J.P., Hibbs J.R., Anderson S., Katevas P., and Young N.S. Phenotypic and functional analysis of bone marrow progenitor cell compartment in bone marrow failure. Br J Haematol 126 (1997) 166-168
28. Young N.S. Autoimmunity and its treatment in aplastic anemia. Ann Intern Med 126 (1997) 166-168
29. Gordon M.Y. Stem cells and the microenvironment in aplastic anaemia. Br J Haematol 86 (1994) 190-192
30. Holmberg L.A., Seidel K., Leisenring W., and Torok-Storb B. Aplastic anemia: analysis of stromal cell function in long-term marrow cultures. Blood 84 (1994) 3685-3690
31. Gordon-Smith E.C., Yanelle A., and Miline A. Randomized placebo controlled study of rhu GM-CSF following ALG in the treatment of aplastic anaemia. Bone Marrow Transplant 2 suppl 2 (1991) 78
32. Gluckman E., Rokicka-Milewska R., Hann I., et al. Results and follow-up of a phase III randomized study of recombinant human-granulocyte stimulating factor as support for immunosuppressive therapy in patients with severe aplastic anaemia. Br J Haematol 119 (2002) 1075-1082
33. Teramura M., Kobayashi S., Inabe K., Yoshinaga K., and Mizoguchi H. Mechanism of action of antithymocyte globulin in the treatment of aplastic anaemia: in vitro evidence for the presence of immunosuppressive mechanism. Br J Haematol 96 (1997) 80-84
34. Taniguchi Y., Frickhofen N., Raghavachar A., Digel W., and Heimpel H. Antilymphocyte immunoglobulins stimulate peripheral blood lymphocytes to proliferate and release lymphokines. Eur J Haematol 44 (1990) 244-251
35. Flynn J., Cox C.V., Rizzo S., et al. Direct binding of antithymoctye globulin to haemopoietic progenitor cells in aplastic anaemia. Br J Haematol 122 (2003) 289-297
36. + cells in aplastic anaemia and myelodysplasia. Br J Haematol 108 (2000) 582-591
37. Eiermann T.H., Freitag S., Cortes-Dericks L., Sahm H., and Zander A.R. Jurkat cell-reactive anti-thymocyte globulin assessed ex vivo by flow cytometry persists three weeks in circulation. J Hematother Stem Cell Res 10 (2001) 385-390
38. Tichelli A., Gratwohl A., Wursch A., Nissen C., and Speck B. Late haematological complications in severe aplastic anaemia. Br J Haematol 69 (1998) 413-418
39. Socie G., Henry-Amar M., Bacigalupo A., et al. Malignant tumors occurring after treatment of aplastic anemia. N Engl J Med 329 (1993) 1152-1157